Drawing for GTC BIOLOGICS

USPTO serial 78117247

GTC BIOLOGICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MAYS, PAULA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GTC BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DEBRA S. SEROTA

CYNTHIA JOHNSON WALDEN, FISH & RICHARDSOPO BOX 1022MINNEAPOLIS, MN 55440-1022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for use in scientific or medical research; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use in the manufacture of pharmaceuticals and reagents; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms and for use in scientific or medical research; cells, cell lines and cell cultures for use in scientific and medical research; transgenic and cloned animal products, namely meat, tissue, cells or secretions for use in scientific or medical researchACTIVE—
005-- Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use as medical therapeutic reagents; transgenic and cloned animal products, namely, meat, tissue, cells or secretions for therapeutic and diagnostic useACTIVE—
031Live laboratory animals and live transgenic animalsACTIVE—
040Processing and purifying of antithrombin III, recombinant human albumin, decorin, cystic fibrosis transmembrane conductance regulator, prolactin and urokinase obtained from the milk of transgenic animals, and cloned animals for use in medical and scientific research and for therapeutic and diagnostic use; custom manufacture of pharmaceuticals, biopharmaceuticals, proteins, cell culture and transgenic animal productsACTIVE—
042Providing technical advice, research, testing and analysis in the fields of biotechnology, molecular biology, chemistry, genetics, genetic engineering, pharmaceutical production, isolation of pharmaceutical and nutritive and dietetic substances, genealogy, chemicals, and pharmaceutical drug development; pharmaceutical drug development; medical research services in the nature of medical engineering services and genetic engineering services; isolation of pharmaceutical and nutritive and dietetic substances for research purposesACTIVE—
044Isolation of pharmaceutical and nutritive and dietetic substances for medical purposes; medical testing services in the nature of medical engineering and genetic engineering of cloned and transgenic animals; animal breeding; transgenic and cloned animal breeding; animal husbandry, veterinary services; veterinary surgery; providing for the care and use of transgenic or cloned animals and products there fromACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 5, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 5, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 13, 2006EX3GSOU EXTENSION 3 GRANTED—
Apr 13, 2006EXT3SOU EXTENSION 3 FILED—
Apr 13, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 2, 2005EX2GSOU EXTENSION 2 GRANTED—
Oct 20, 2005EXT2SOU EXTENSION 2 FILED—
Oct 20, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 29, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 7, 2005EX1GSOU EXTENSION 1 GRANTED—
Feb 7, 2005EXT1SOU EXTENSION 1 FILED—
Feb 7, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 2, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 2, 2004CFITCASE FILE IN TICRS—
Aug 18, 2004ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 15, 2003ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 28, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 8, 2003NPUBNOTICE OF PUBLICATION—
Sep 5, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2003CNEAEXAMINERS AMENDMENT MAILED—
Aug 25, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 31, 2003ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 28, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2003MAILPAPER RECEIVED—
Apr 14, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2003ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 14, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 15, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 15, 2003MAILPAPER RECEIVED—
Jul 15, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance